Welcome to our dedicated page for CENTENE SEC filings (Ticker: CNC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on CENTENE's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into CENTENE's regulatory disclosures and financial reporting.
Centene Corp director Frederick H. Eppinger received a stock grant. On this date, he acquired 833 shares of Centene common stock at no stated purchase price as a grant or award. Following this award, his directly held position increased to 369,537.658 shares, including 6,654 restricted stock units that are subject to vesting requirements.
Centene director Christopher J. Coughlin reported updated equity holdings, including a new share award. He received a grant of 562 shares of Centene common stock at no cost, classified as a grant or award acquisition and held directly, bringing his direct holdings to 18,710.926 shares.
Coughlin also reports 30,054 shares of common stock held indirectly through a grantor retained annuity trust for the benefit of himself and his adult children, where he serves as sole trustee. Footnotes state his ownership includes 3,992 restricted stock units that are subject to vesting requirements.
Centene Corp director Lauren M. Tyler filed an initial Form 3 indicating no securities beneficially owned in the company. The filing shows zero shares held directly after the reported position. This is a baseline ownership disclosure rather than a buy or sell transaction.
Centene Corporation has expanded its Board of Directors from nine to ten members and appointed Lauren M. Tyler as a director effective June 19, 2026, with a term running through the 2027 annual meeting of stockholders.
She is expected to join the Audit Committee and the Compensation and Talent Committee on July 1, 2026. Tyler brings more than 30 years of leadership experience, including senior roles at JPMorgan Chase & Co., and currently serves on the boards of Cencora, Inc. and Guardian Life. She will receive compensation under Centene’s standard non-employee director program, and the company issued a press release describing her appointment.
Centene Corp Chief Operating Officer Susan Raye Smith reported a tax-related share disposition linked to equity compensation. On this Form 4, 483 shares of Centene common stock were withheld at $65.19 per share to cover taxes upon vesting of a previously reported restricted stock unit grant.
After this tax-withholding disposition, Smith directly owns 212,237 shares of Centene common stock. Her ownership also includes 181,082 shares tied to previously granted restricted stock units and performance stock units, which remain subject to vesting requirements.
Centene Corp director Kenneth A. Burdick reported an open-market sale of 80,000 shares of Centene common stock at $64.55 per share. A footnote explains that the weighted average sale price reflects trades between $64.55 and $64.61 per share, with detailed breakdowns available on request.
Following this sale, Burdick directly holds 197,085.924 Centene shares, which include 3,992 restricted stock units subject to vesting requirements. Separately, 86,498 Centene shares are held indirectly by the Burdick Family LLC, where he is a chief manager but disclaims beneficial ownership beyond his pecuniary interest.
Centene Group President Michael A. Carson reported a discretionary transaction involving phantom stock tied to Centene common shares. He reallocated 604.004 phantom stock units under the company’s nonqualified deferred compensation plan from an investment option tracking Centene stock to an alternative investment option, at a reference price of $59.60 per share. The filing states this did not involve any open market sale of securities.
Following the update, Carson reports ownership of 122,882 shares of common stock directly and 825 shares indirectly through his spouse. His holdings include 113,747 previously granted restricted stock units and performance stock units that remain subject to vesting. The phantom stock will be settled in cash or other non‑Centene securities upon his termination or another date he elects.
Centene Group President Michael A. Carson increased his deferred compensation exposure by acquiring 47.935 shares of phantom stock at $57.7700 per unit. Each phantom share represents the right to receive the fair market value of one Centene common share.
The phantom stock was obtained through regularly scheduled payroll contributions to the company’s deferred compensation plan and has no formal expiration date. After this award, Carson holds 604.004 phantom stock units, 122,882 shares of common stock held directly (including 113,747 restricted and performance stock units subject to vesting), and 825 common shares held indirectly by his spouse.
Centene Corporation executive Daniel P. Finke, Group President, Markets & Comm, has filed an initial ownership report showing compensation-based equity holdings in the company. The filing lists 228,127 restricted stock units, which are scheduled to vest in three equal installments on each anniversary of the grant date beginning April 15, 2027. These holdings represent stock-based awards rather than recent open-market share purchases or sales.